Skip to main content
. 2022 Jan 7;3(1):79–90. doi: 10.1016/j.hroo.2021.12.005

Figure 3.

Figure 3

Medication usage during follow-up. A: Oral anticoagulant usage. B: Antiarrhythmic medication usage. C: Rate medication usage. Data indicate the percentage of patients with at least 1 day of prescription coverage for the medication during the 3-month period. Oral anticoagulants include both non–vitamin K antagonist oral anticoagulants and warfarin. ∗Statistically significant difference between the 2 cohorts. ICM = insertable cardiac monitor.